Vistin Pharma ASA announced that the two-year election period for the Board member, Finn Bjørn Ruyter expires in May 2019. It is proposed that Espen Marcussen is re-placing member of board, Finn Bjørn Ruyter and elected for a period of two years. Espen Marcussen is the CEO of Pactum AS, one of the larger shareholders in Vistin Pharma ASA, and has previously held the position as Deputy CEO in Bergshav Management AS and as Head of Investment Banking in Nordea.